Healthcare & Life Sciences
Oxford Brain Diagnostics
United Kingdomoxfordbraindiagnostics.com
activeseries-a
series-a
Stage
1
Investors
About
Oxford Brain Diagnostics develops Cortical Disarray Measurement (CDM) technology that analyzes MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases such as Alzheimer's and Parkinson's.
Explore Oxford Brain Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.